These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1614112)

  • 21. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma.
    Tokunaga T; Kashiwagi K; Tsumura T; Taguchi K; Tsukahara S
    Jpn J Ophthalmol; 2004; 48(4):380-5. PubMed ID: 15295667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraocular pressure as a risk factor for visual field loss in pseudoexfoliative and in primary open-angle glaucoma.
    Teus MA; Castejón MA; Calvo MA; Pérez-Salaíces P; Marcos A
    Ophthalmology; 1998 Dec; 105(12):2225-9; discussion 2229-30. PubMed ID: 9855151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study.
    Iwase A; Suzuki Y; Araie M; Yamamoto T; Abe H; Shirato S; Kuwayama Y; Mishima HK; Shimizu H; Tomita G; Inoue Y; Kitazawa Y;
    Ophthalmology; 2004 Sep; 111(9):1641-8. PubMed ID: 15350316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open-angle glaucoma: a randomized, controlled, investigator-blinded study.
    Reis R; dos Santos LC; Vila MP; Magacho L
    Clin Ther; 2004 Dec; 26(12):2121-7. PubMed ID: 15823775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of chronic primary open-angle glaucoma. Long-term functional results].
    Demailly P; Gruber D; Kretz G
    J Fr Ophtalmol; 1989; 12(8-9):527-34. PubMed ID: 2699612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma.
    Konstas AG; Tsironi S; Vakalis AN; Nasr MB; Stewart JA; Nelson LA; Stewart WC
    Acta Ophthalmol; 2009 Feb; 87(1):71-6. PubMed ID: 19178390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
    Konstas AG; Katsimbris JM; Lallos N; Boukaras GP; Jenkins JN; Stewart WC
    Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined phacoemulsification and goniotrephination in primary open-angle glaucoma and pseudoexfoliation glaucoma - a retrospective analysis].
    Heuring AH; Hütz WW; Eckhardt HB
    Klin Monbl Augenheilkd; 2001 Aug; 218(8):535-41. PubMed ID: 11573154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of the effectiveness of beta-blockers for intraocular pressure and visual field in primary open-angle glaucoma].
    Dobre X
    Oftalmologia; 2008; 52(4):95-9. PubMed ID: 19354170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Modification of the visual field during temporary interruption of miotic treatment].
    Fitting PL; Mermoud A
    Klin Monbl Augenheilkd; 1992 May; 200(5):481-3. PubMed ID: 1614131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Naftidrofuryl in the treatment of simple diabetic retinopathy. A double-blind study].
    Klein M; Hirche H
    Klin Monbl Augenheilkd; 1985 Sep; 187(3):195-201. PubMed ID: 3906248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxium (calcium dobesilate) reduces blood hyperviscosity and lowers elevated intraocular pressure in patients with diabetic retinopathy and glaucoma.
    Vojnikovic B
    Ophthalmic Res; 1991; 23(1):12-20. PubMed ID: 1870835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual field protective effect of Erigeron breviscapus (vant.) Hand. Mazz. extract on glaucoma with controlled intraocular pressure: a randomized, double-blind, clinical trial.
    Zhong Y; Xiang M; Ye W; Cheng Y; Jiang Y
    Drugs R D; 2010; 10(2):75-82. PubMed ID: 20698715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of naftidrofuryl (Praxilene) on intermittent claudication.
    Waters KJ; Craxford AD; Chamberlain J
    Br J Surg; 1980 May; 67(5):349-51. PubMed ID: 6992910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
    Trübestein G; Böhme H; Heidrich H; Heinrich F; Hirche H; Maass U; Mörl H; Rudofsky G
    Angiology; 1984 Nov; 35(11):701-8. PubMed ID: 6388425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naftidrofuryl: a review of its use in the treatment of intermittent claudication.
    Goldsmith DR; Wellington K
    Drugs Aging; 2005; 22(11):967-77. PubMed ID: 16323973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A controlled trial of naftidrofuryl (Praxilene) in the treatment of intermittent claudication.
    Clyne CA; Galland RB; Fox MJ; Gustave R; Jantet GH; Jamieson CW
    Br J Surg; 1980 May; 67(5):347-8. PubMed ID: 6992909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.